Northwest Biotherapeutics Inc logo

Northwest Biotherapeutics Inc

NEW
STU:NBYB (USA)  
€ 0.17 +0.040 (+30.77%) Aug 7
At Loss
Market Cap:
€ 261.82M ($ 302.70M)
Enterprise V:
€ 315.81M ($ 365.12M)
Volume:
62.31K
Avg Vol (2M):
27.83K
Trade In:
Volume:
62.31K
At Loss

Northwest Biotherapeutics Inc (STU:NBYB) Dividend

Northwest Biotherapeutics Inc (STU:NBYB) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -13.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:NBYB Dividend

Does Northwest Biotherapeutics Inc (STU:NBYB) pay a dividend?

Northwest Biotherapeutics Inc (STU:NBYB) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Northwest Biotherapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Northwest Biotherapeutics Inc has returned capital to shareholders via buybacks at a rate of -13.3% over the past 3 years.

What are dividend-paying alternatives to Northwest Biotherapeutics Inc?

For dividend-paying alternatives in Northwest Biotherapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.